{
  "report_rows": [
    {
      "kpi": "Organic net sales growth",
      "prediction": "BEAT",
      "answer": "pred ~(3.2)% vs. cons (3.5)%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.30B vs. cons $1.28B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.55 vs. cons $0.53",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 organic net sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~(1.5)% to (3.5)% vs. cons ~(2.5)% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.98 to $2.10 vs. cons $2.04 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted gross-margin change",
      "prediction": "UNCHANGED",
      "answer": "guide ~(25) to (75) bps vs. cons ~(50) bps (FY26)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A ~3.0% day-1 residual reaction should extend toward ~4.0% over five days if a modest 2Q beat is paired with unchanged FY26 guide math, improving share commentary, and no implied out-period EPS cut.",
  "day5_confidence": "MEDIUM"
}